Interview of Saniona CEO, Rami Levin, about the results of the phase 2 trial of Tesomet. - a podcast by Eugenie Hsu

from 2020-05-08T16:14:51

:: ::

New Hope for HO: Tesomet is a new drug being trialed for Prader-Willi syndrome and Hypothalamic Obesity. Rami Levin describes the successful phase 2 trial results.

---

Send in a voice message: https://anchor.fm/euge3/message